General
Johnson & Johnson single-dose vaccine shown to be effective against COVID-19
Johnson & Johnson’s (J&J) vaccine candidate appears to protect against COVID-19 with just one shot of the dose.
Key points:
- Johnson & Johnson says trial results show its one-shot vaccine is 66 per cent effective against COVID-19
- While promising, it is still behind many rivals who are using a two-shot vaccine
- The company says trying to create a vaccine which requires one shot is worthwhile as the virus continues to spread
The single-shot option is not as strong as some of its two-shot rivals, however it could be potentially helpful for a world in dire need of more doses.
J&J said on Friday that in the US and seven other countries, the single-shot vaccine was 66 per cent per cent effective overall at preventing moderate to severe illness.
The…
Continue Reading
-
Noosa News23 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News23 hours agoRising talent shine at Noosa International Surfilm Festival 2025
-
Business24 hours agoSuncorp shares push higher on big leadership news
-
Noosa News21 hours agoNSW cattle breeder pleads not guilty to more than a dozen fraud charges